Inter J Stomatol ›› 2018, Vol. 45 ›› Issue (1): 32-35.doi: 10.7518/gjkq.2018.01.006
• Original Articles • Previous Articles Next Articles
Wang Yang1, Shen Yuqin2, Yu Wenwen1, Sun Xinhua1
CLC Number:
[1]Hench LL, Jones JR. Bioactive glasses: frontiers and challenges[J]. Front Bioeng Biotechnol, 2015, 3:194. [2]Kaur G, Pickrell G, Kimsawatde G et al. Synthesis, cytotoxicity, and hydroxyapatite formation in 27- Tris-SBF for sol-gel based CaO-P 2 O 5 -SiO 2 -B 2 O 3 -ZnO bioactive glasses[J]. Sci Rep, 2014, 4:4292. [3]张爱娟, 高增丽. 硼对模拟体液中生物活性玻璃矿化速度的影响[J]. 硅酸盐通报, 2015, 34(12):3721- 3725 Zhang AJ, Gao ZL. The effect of boron on bioactive glass mineralization rate in simulated humors[J]. Bull Chin Ceramic Soc, 2015, 34(12):3721-3725. [4]Azevedo MM, Tsigkou O, Nair R, et al. Hypoxia inducible factor-stabilizing bioactive glasses for di-recting mesenchymal stem cell behavior[J]. Tissue Eng Part A, 2015, 21(1/2):382-389. [5]Coraça-Huber DC, Fille M, Hausdorfer J, et al. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro [J]. J Orthop Res, 2014, 32(1):175-177. [6]贺金晶. 含铜介孔生物活性玻璃/多孔羟基磷灰石复合支架的制备及其义眼座应用的基础研究[D]. 杭州: 浙江大学, 2014. He JJ. Preparation of bioactive glass/porous hydro-xyapatite composite scaffolds and basic research on the application of the prosthetic eyes[D]. Hangzhou:Zhejiang University, 2014. [7]Zhao L, Yan X, Zhou X, et al. Mesoporous bioactive glasses for controlled drug release[J]. Microporo Mesoporo Mater, 2008, 109(1/2/3):210-215. [8]Hong Y, Chen X, Jing X, et al. Preparation, bioac-tivity, and drug release of hierarchical nanoporous bioactive glass ultrathin fibers[J]. Adv Mater, 2010, 22(6):754-758. [9]刘涛. 丝素蛋白、介孔生物玻璃陶瓷骨修复复合材料的制备与性能研究[D]. 杭州: 浙江大学, 2014. Liu T. Preparation and properties of fibroin and mesoporous ceramic bone repair composite materials [D]. Hangzhou: Zhejiang University, 2014. [10]车晨, 耿亚亚, 郝葆青. 生物活性玻璃分子生物学特性的研究进展[J]. 内蒙古农业大学学报(自然科学版), 2015, 36(1):179-183. Che C, Geng YY, Hao BQ. Advances in molecular biological characteristics of bioactive glass[J]. J Inner Mongolia Argicul Univer (Nat Sci Ed), 2015, 36(1):179-183. [11]Wu C, Zhou Y, Xu M, et al. Copper-containing mesoporous bioactive glass scaffolds with multifunc-tional properties of angiogenesis capacity, osteos-timulation and antibacterial activity[J]. Biomaterials, 2013, 34(2):422-433. [12]张学广. 胶原膜及生物活性玻璃用于颌骨囊肿骨缺损修复[J]. 现代口腔医学杂志, 2002, 16(5):429- 430. Zhang XG. Collagen membrane and bioactive glass used in the repair of bone defect of maxilla cyst[J]. J Moden Stomatol, 2002, 16(5):429-430. [13]Stoor P, Mesimäki K, Lindqvist C, et al. The use of anatomically drop-shaped bio-active glass S53P4 implants in the reconstruction of orbital floor frac-tures—a prospective long-term follow-up study[J]. J Cranio-maxillo-fac Surg, 2015, 43(6):969-975. [14]van Gestel NAP, Geurts J, Hulsen DJW, et al. Clin-ical applications of S53P4 bioactive glass in bone healing and osteomyelitic treatment: a literature review[J]. 2015, 2015:684826. [15]McAndrew J, Efrimescu C, Sheehan E, et al. Through the looking glass: bioactive glass S53P4 (Bone Alive ® ) in the treatment of chronic osteomyelitis[J]. Ir J Med Sci, 2013, 182(3):509-511. [16]Drago L, Romanò D, De Vecchi E, et al. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study[J]. BMC Infect Dis, 2013, 13:584. [17]Detsch R, Stoor P, Grünewald A, et al. Increase in VEGF secretion from human fibroblast cells by bioactive glass S53P4 to stimulate angiogenesis in bone[J]. J Biomed Mater Res A, 2014, 102(11):4055- 4061. [18]Lindfors NC, Koski I, Heikkilä JT, et al. A prospec-tive randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors[J]. J Biomed Mater Res B Appl Biomater, 2010, 94(1):157-164. |
[1] | Yingyou He,Sen Hu,Jihua Li. Clinical research progress on surgically assisted rapid maxillary expansion [J]. Int J Stomatol, 2019, 46(3): 343-348. |
[2] | Qiao Xianghe, Li Longjiang.. Immediate reconstruction of orbital floor defect after maxillary tumor resection [J]. Inter J Stomatol, 2017, 44(6): 737-742. |